Home / Stocks / DVA

DaVita (DVA, Health Care Services) Stock Valuation & Fair Value Quality business with a solid forward outlook

DaVita (DVA, Health Care Services) trades at a blended P/E of 13.2, about 19% below its historical normal valuation, with a forward growth estimate of 18.5% and a PEG of 0.71. Analysts' one-year estimates have been hit 36% of the time.

DATA AS OF 2026-08-21
Blended P/E
13.2
Normal P/E
16.2
PEG
0.71
Fwd growth
18.5%
Div yield
0.0%
RSI (14)
23.9
Oversold

The Street vs SeerForecast

Wall Street's mean price target for DVA is $218.43 across 7 analysts, 25.7% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: quality business with a solid forward outlook. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been quality business with a solid forward outlook since 2026-06-03.

Price and rating by weekClose moved -7.7 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Quality business with a solid forward outlook, close 195.03 (recalculated)2026-06-10: Quality business with a solid forward outlook, close 198.54 (recalculated)2026-06-14: Quality business with a solid forward outlook, close 208.66 (recalculated)2026-06-16: Quality business with a solid forward outlook, close 208.98 (recalculated)2026-06-21: Quality business with a solid forward outlook, close 207.91 (recalculated)2026-07-02: Quality business with a solid forward outlook, close 234.91 (recalculated)2026-07-06: Quality business with a solid forward outlook, close 235.71 (recalculated)2026-07-09: Quality business with a solid forward outlook, close 229.48 (recalculated)2026-07-12: Quality business with a solid forward outlook, close 232.80 (recalculated)2026-07-13: Quality business with a solid forward outlook, close 235.58 (recalculated)2026-07-14: Quality business with a solid forward outlook, close 232.41 (recalculated)2026-07-20: Quality business with a solid forward outlook, close 234.10 (recalculated)2026-07-22: Quality business with a solid forward outlook, close 232.08 (recalculated)2026-07-25: Quality business with a solid forward outlook, close 235.44 (recalculated)2026-07-27: Quality business with a solid forward outlook, close 236.31 (recalculated)2026-07-31: Quality business with a solid forward outlook, close 240.09 (recalculated)2026-08-03: Quality business with a solid forward outlook, close 240.092026-08-07: Quality business with a solid forward outlook, close 183.77 (recalculated)2026-08-10: Quality business with a solid forward outlook, close 183.772026-08-14: Quality business with a solid forward outlook, close 180.06 (recalculated)2026-08-17: Quality business with a solid forward outlook, close 180.061951802026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 16.0-1%Quality business with a solid forward outlook
2026-06-10P/E 15.5-4%Quality business with a solid forward outlook
2026-06-14P/E 15.5-4%Quality business with a solid forward outlook
2026-06-16P/E 15.5-4%Quality business with a solid forward outlook
2026-06-21P/E 15.5-4%Quality business with a solid forward outlook
2026-07-02P/E 18.0+11%Quality business with a solid forward outlook
2026-07-06P/E 18.5+14%Quality business with a solid forward outlook
2026-07-09P/E 18.5+14%Quality business with a solid forward outlook
2026-07-12P/E 18.2+12%Quality business with a solid forward outlook
2026-07-13P/E 18.2+12%Quality business with a solid forward outlook
2026-07-14P/E 18.2+12%Quality business with a solid forward outlook
2026-07-20P/E 18.4+14%Quality business with a solid forward outlook
2026-07-22P/E 18.4+14%Quality business with a solid forward outlook
2026-07-25P/E 18.2+12%Quality business with a solid forward outlook
2026-07-27P/E 18.2+12%Quality business with a solid forward outlook
2026-07-31P/E 18.4+13%Quality business with a solid forward outlook
2026-08-03P/E 18.4+14%Quality business with a solid forward outlook
2026-08-07P/E 13.8-15%Quality business with a solid forward outlook
2026-08-10P/E 13.9-14%Quality business with a solid forward outlook
2026-08-14P/E 13.5-16%Quality business with a solid forward outlook
2026-08-17P/E 13.6-16%Quality business with a solid forward outlook
2026-08-21P/E 13.2-19%Quality business with a solid forward outlook ← now

Frequently asked questions

Is DaVita stock overvalued?

At a blended P/E of 13.2 versus its historical normal P/E of 16.2, DaVita trades about 19% below its typical valuation, with a PEG of 0.71 on 18.5% forward growth. tickerseer currently rates it quality business with a solid forward outlook.

What is DaVita's fair value and PEG?

DaVita trades at a blended P/E of 13.2 against a historical normal P/E of 16.2, a PEG of 0.71, and a forward growth estimate of 18.5%.

Has tickerseer's rating of DaVita changed?

tickerseer's rating has been quality business with a solid forward outlook since 2026-06-03.

What is the analyst price target for DaVita?

The mean Wall Street price target for DaVita is $218.43 across 7 analysts, 25.7% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track DVA free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.